Huang, Can <br/><br/>
In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapy.  [electronic resource] 

 -  Drug delivery  Nov 2017 
 - 459-466 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1521-0464 
<br/><br/><label>Standard No.: </label>10.1080/10717544.2016.1264499  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>A549 Cells<br/>Absorption, Physiological<br/>Animals<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Survival--drug effects<br/>Chitosan--administration & dosage<br/>Drug Carriers--administration & dosage<br/>Fluorouracil--administration & dosage<br/>Glycosylation<br/>Half-Life<br/>Hemolysis--drug effects<br/>Hep G2 Cells<br/>Hepatocytes--drug effects<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Mice<br/>Nanoparticles--adverse effects<br/>Prodrugs--administration & dosage<br/>Rabbits<br/>Random Allocation<br/>Rats, Sprague-Dawley<br/>Tissue Distribution